15,542
Total Claims
$2.5M
Drug Cost
934
Beneficiaries
$2,635
Cost/Patient
Peer Comparison vs. 218,535 Nurse Practitioner providers
-98%
Opioid rate vs peers
0.1% vs 3.8% avg
+124%
Cost per patient vs peers
$2,635 vs $1,174 avg
+74%
Brand preference vs peers
15.4% vs 8.9% avg
Opioid Prescribing
0.1%
Opioid Rate
13
Opioid Claims
$56
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
85% generic
Brand: 2,368 claims · $2.1M
Generic: 13,013 claims · $311K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 458 | $670K |
| Empagliflozin | 136 | $186K |
| Dulaglutide | 79 | $138K |
| Apixaban | 137 | $134K |
| Fluticasone/Umeclidin/Vilanter | 137 | $131K |
| Insulin Glargine,hum.Rec.Anlog | 106 | $86K |
| Semaglutide | 61 | $73K |
| Dapagliflozin Propanediol | 71 | $72K |
| Tirzepatide | 51 | $59K |
| Linaclotide | 50 | $49K |
| Sitagliptin Phosphate | 45 | $45K |
| Insulin Degludec | 46 | $40K |
| Mirabegron | 27 | $38K |
| Fluticasone/Vilanterol | 54 | $37K |
| Budesonide/Formoterol Fumarate | 54 | $29K |
Prescribing Profile
Patient Profile
71
Avg Age
65%
Female
1.25
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data